HK Stock MarketDetailed Quotes

01177 SINO BIOPHARM

Watchlist
  • 3.250
  • -0.010-0.31%
Market Closed Nov 29 16:08 CST
61.07BMarket Cap13.60P/E (TTM)

SINO BIOPHARM Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Cash flow from operating activities
Earning before tax
----
2.68%5.93B
----
-68.89%5.78B
----
270.49%18.57B
----
-11.91%5.01B
----
-50.21%5.69B
Profit adjustment
Interest (income) - adjustment
----
4.28%-192.81M
----
-24.30%-201.44M
----
16.47%-162.06M
----
24.72%-194M
----
-58.37%-257.71M
Dividend (income)- adjustment
----
-513.71%-87.1M
----
-495.59%-14.19M
----
47.42%-2.38M
----
-16.56%-4.53M
----
68.02%-3.89M
Investment loss (gain)
----
-14.51%-342.56M
----
24.35%-299.15M
----
-22.91%-395.45M
----
-9.01%-321.75M
----
23.00%-295.16M
Attributable subsidiary (profit) loss
----
243.65%525.71M
----
101.12%152.98M
----
-421,714.29%-13.63B
----
102.90%3.23M
----
-85.92%-111.39M
Impairment and provisions:
----
-152.56%-12.26M
----
-96.71%23.33M
----
787.28%708.38M
----
33.00%79.84M
----
-8.50%60.03M
-Impairment of property, plant and equipment (reversal)
----
----
----
----
----
-72.51%3.75M
----
--13.64M
----
----
-Impairment of trade receivables (reversal)
----
-412.28%-12.26M
----
142.20%3.93M
----
--1.62M
----
----
----
----
-Impairment of goodwill
----
----
----
----
----
--47.25M
----
----
----
----
-Other impairments and provisions
----
----
----
-97.04%19.4M
----
890.55%655.75M
----
10.28%66.2M
----
-8.50%60.03M
Revaluation surplus:
----
-77.66%63.39M
----
681.04%283.71M
----
106.84%36.33M
----
-5,092.93%-531.45M
----
-76.27%10.64M
-Derivative financial instruments fair value (increase)
----
99.79%-161K
----
68.60%-75.7M
----
-173.92%-241.07M
----
---88.01M
----
----
-Other fair value changes
----
-82.32%63.55M
----
29.57%359.41M
----
162.56%277.4M
----
-4,266.08%-443.44M
----
-76.27%10.64M
Asset sale loss (gain):
----
-8,401.27%-294.57M
----
-181.00%-3.47M
----
621.42%4.28M
----
101.00%593K
----
99.10%-59.15M
-Available for sale investment sale loss (gain)
----
----
----
----
----
----
----
----
----
---73.93M
-Loss (gain) from sale of subsidiary company
----
---231.88M
----
----
----
----
----
----
----
----
-Loss (gain) on sale of property, machinery and equipment
----
-1,709.21%-62.69M
----
-181.00%-3.47M
----
621.42%4.28M
----
-95.99%593K
----
338.20%14.79M
Depreciation and amortization:
----
2.61%1.07B
----
5.48%1.05B
----
-40.02%992.56M
----
14.47%1.65B
----
19.45%1.45B
-Amortization of intangible assets
----
7.29%109.1M
----
13.09%101.69M
----
-88.22%89.92M
----
-2.97%763.49M
----
8.21%786.83M
Financial expense
----
16.40%511.07M
----
42.27%439.06M
----
-4.56%308.62M
----
40.63%323.37M
----
50.04%229.95M
Special items
----
-56.23%64.09M
----
--146.42M
----
----
----
----
----
----
Operating profit before the change of operating capital
----
-1.50%7.24B
----
14.31%7.35B
----
6.79%6.43B
----
-10.23%6.02B
----
17.93%6.71B
Change of operating capital
Inventory (increase) decrease
----
134.60%135.32M
----
-580.47%-391.1M
----
74.05%-57.48M
----
50.73%-221.45M
----
-339.93%-449.44M
Accounts receivable (increase)decrease
----
-36.03%-639.41M
----
70.90%-470.06M
----
-975.26%-1.62B
----
-176.52%-150.22M
----
145.00%196.31M
Accounts payable increase (decrease)
----
-37.28%696.68M
----
29.49%1.11B
----
19.61%857.86M
----
217.31%717.19M
----
-81.97%226.02M
prepayments (increase)decrease
----
7.52%-480.79M
----
-226.96%-519.9M
----
293.39%409.49M
----
-4.09%-211.74M
----
56.41%-203.41M
Special items for working capital changes
----
-290.73%-142.32M
----
12.64%74.62M
----
-48.06%66.25M
----
343.93%127.55M
----
-849.67%-52.29M
Cash  from business operations
----
-4.82%6.81B
----
17.47%7.16B
----
-3.05%6.09B
----
-2.21%6.28B
----
8.32%6.43B
Other taxs
----
16.31%-746.57M
----
-22.76%-892.09M
----
24.24%-726.72M
----
12.97%-959.18M
----
-31.43%-1.1B
Special items of business
15.25%3.08B
----
-32.36%2.67B
----
69.08%3.95B
----
50.14%2.34B
----
-55.65%1.56B
----
Net cash from operations
15.25%3.08B
-3.18%6.07B
-32.36%2.67B
16.75%6.27B
69.08%3.95B
0.77%5.37B
50.14%2.34B
0.01%5.33B
-55.65%1.56B
4.52%5.32B
Cash flow from investment activities
Interest received - investment
----
-4.28%192.81M
----
24.30%201.44M
----
-16.47%162.06M
----
-21.25%194M
----
68.89%246.36M
Dividend received - investment
--751.5M
-44.83%492.91M
----
-77.76%893.45M
----
46,383.92%4.02B
----
122.33%8.64M
----
-68.02%3.89M
Loan receivable (increase) decrease
----
----
----
318.80%70.43M
----
39.71%-32.19M
----
13.97%-53.39M
----
-1,873.17%-62.06M
Decrease in deposits (increase)
-38.37%-3.8B
107.86%300.52M
-5.42%-2.74B
-62.20%-3.82B
-510.08%-2.6B
-6.87%-2.36B
--634.89M
-162.80%-2.2B
----
-1,623.13%-838.99M
Sale of fixed assets
----
262.09%100.99M
----
-78.90%27.89M
----
30.69%132.2M
----
60.31%101.15M
----
267.66%63.09M
Purchase of fixed assets
45.95%-407.5M
14.12%-1.07B
-20.25%-753.91M
27.47%-1.24B
-7.06%-626.97M
-20.35%-1.71B
---585.61M
1.74%-1.42B
----
6.48%-1.45B
Purchase of intangible assets
----
-34.28%-406.78M
----
-98.10%-302.94M
----
57.99%-152.92M
----
-27.95%-363.99M
----
-123.93%-284.48M
Sale of subsidiaries
--1.41B
383.11%413.81M
----
---146.17M
----
----
----
----
----
18.88%170M
Acquisition of subsidiaries
----
---1.16B
--458K
----
----
---798.75M
---757.16M
----
----
-137.00%-391.67M
Recovery of cash from investments
----
0.53%512.22M
----
1.16%509.52M
----
65.28%503.67M
----
-5.53%304.74M
----
-15.84%322.58M
Cash on investment
-338.86%-1.69B
47.99%-130.39M
88.60%-384.45M
90.59%-250.71M
-116.05%-3.37B
70.73%-2.66B
---1.56B
-890.78%-9.1B
----
-292.36%-918.71M
Other items in the investment business
980.62%1.69B
-5.58%-8.74M
-131.32%-191.99M
-102.14%-8.28M
134.29%612.94M
-91.77%386.51M
-16.54%-1.79B
785.50%4.69B
30.61%-1.53B
44.56%-684.88M
Net cash from investment operations
49.91%-2.04B
81.40%-756.98M
31.97%-4.07B
-61.80%-4.07B
-47.68%-5.99B
67.93%-2.52B
-164.48%-4.06B
-105.15%-7.85B
30.61%-1.53B
-520.73%-3.82B
Net cash before financing
173.92%1.04B
141.93%5.31B
31.22%-1.4B
-23.01%2.19B
-18.62%-2.04B
213.10%2.85B
-7,932.88%-1.72B
-267.98%-2.52B
-98.31%21.96M
-66.50%1.5B
Cash flow from financing activities
New borrowing
-38.57%6.71B
25.03%12.19B
41.55%10.93B
593.65%9.75B
1,310.46%7.72B
-8.57%1.41B
--547.29M
-81.68%1.54B
----
2,006.73%8.39B
Refund
7.91%-9.4B
-46.25%-10.28B
-55.11%-10.2B
-174.02%-7.03B
-716.55%-6.58B
-45.80%-2.57B
---805.6M
44.93%-1.76B
----
-3,306.59%-3.2B
Interest paid - financing
----
-41.62%-480.83M
----
-89.02%-339.52M
----
16.57%-179.62M
----
36.60%-215.31M
----
-121.58%-339.6M
Dividends paid - financing
-62.85%-889.22M
-29.99%-3.85B
-494.20%-546.05M
-119.42%-2.97B
70.83%-91.9M
50.22%-1.35B
---315.04M
-34.33%-2.71B
----
-15.33%-2.02B
Issuance expenses and redemption of securities expenses
90.73%-361.55M
-58.22%-4.02B
-65.88%-3.9B
-327.88%-2.54B
---2.35B
-203.81%-593.56M
----
-509.59%-195.37M
----
94.70%-32.05M
Other items of the financing business
48.00%-164.97M
-376.78%-63.52M
-101.50%-317.28M
-83.63%22.95M
16.39%-157.46M
-97.51%140.16M
-103.69%-188.34M
19,766.73%5.63B
513.25%5.11B
2.82%28.34M
Net cash from financing operations
-1.42%-4.1B
-105.53%-6.55B
-176.76%-4.04B
1.21%-3.19B
-91.75%-1.46B
-244.42%-3.23B
-114.90%-761.69M
-20.27%2.23B
513.25%5.11B
228.61%2.8B
Effect of rate
-69.04%26.27M
91.29%90.52M
358.23%84.83M
107.28%47.32M
71.12%-32.85M
-332.03%-649.71M
-17.28%-113.77M
194.59%280.02M
-394.28%-97M
-60.80%95.05M
Net Cash
43.77%-3.06B
-25.02%-1.24B
-55.54%-5.45B
-164.59%-992.05M
-41.06%-3.5B
-30.63%-374.95M
-148.36%-2.48B
-106.67%-287.03M
8,370.28%5.13B
86.96%4.3B
Begining period cash
-13.28%7.51B
-9.84%8.65B
-9.84%8.65B
-9.64%9.6B
-9.64%9.6B
-0.07%10.62B
-0.07%10.62B
70.51%10.63B
70.51%10.63B
68.88%6.24B
Cash at the end
35.69%4.47B
-13.28%7.51B
-45.69%3.29B
-9.84%8.65B
-24.45%6.07B
-9.64%9.6B
-48.76%8.03B
-0.07%10.62B
147.55%15.67B
70.51%10.63B
Cash balance analysis
Cash and bank balance
----
----
----
----
-24.46%4.21B
----
-38.23%5.58B
----
111.68%9.03B
----
Cash and cash equivalent balance
----
----
----
----
-24.46%4.21B
----
-38.23%5.58B
----
111.68%9.03B
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019
Cash flow from operating activities
Earning before tax ----2.68%5.93B-----68.89%5.78B----270.49%18.57B-----11.91%5.01B-----50.21%5.69B
Profit adjustment
Interest (income) - adjustment ----4.28%-192.81M-----24.30%-201.44M----16.47%-162.06M----24.72%-194M-----58.37%-257.71M
Dividend (income)- adjustment -----513.71%-87.1M-----495.59%-14.19M----47.42%-2.38M-----16.56%-4.53M----68.02%-3.89M
Investment loss (gain) -----14.51%-342.56M----24.35%-299.15M-----22.91%-395.45M-----9.01%-321.75M----23.00%-295.16M
Attributable subsidiary (profit) loss ----243.65%525.71M----101.12%152.98M-----421,714.29%-13.63B----102.90%3.23M-----85.92%-111.39M
Impairment and provisions: -----152.56%-12.26M-----96.71%23.33M----787.28%708.38M----33.00%79.84M-----8.50%60.03M
-Impairment of property, plant and equipment (reversal) ---------------------72.51%3.75M------13.64M--------
-Impairment of trade receivables (reversal) -----412.28%-12.26M----142.20%3.93M------1.62M----------------
-Impairment of goodwill ----------------------47.25M----------------
-Other impairments and provisions -------------97.04%19.4M----890.55%655.75M----10.28%66.2M-----8.50%60.03M
Revaluation surplus: -----77.66%63.39M----681.04%283.71M----106.84%36.33M-----5,092.93%-531.45M-----76.27%10.64M
-Derivative financial instruments fair value (increase) ----99.79%-161K----68.60%-75.7M-----173.92%-241.07M-------88.01M--------
-Other fair value changes -----82.32%63.55M----29.57%359.41M----162.56%277.4M-----4,266.08%-443.44M-----76.27%10.64M
Asset sale loss (gain): -----8,401.27%-294.57M-----181.00%-3.47M----621.42%4.28M----101.00%593K----99.10%-59.15M
-Available for sale investment sale loss (gain) ---------------------------------------73.93M
-Loss (gain) from sale of subsidiary company -------231.88M--------------------------------
-Loss (gain) on sale of property, machinery and equipment -----1,709.21%-62.69M-----181.00%-3.47M----621.42%4.28M-----95.99%593K----338.20%14.79M
Depreciation and amortization: ----2.61%1.07B----5.48%1.05B-----40.02%992.56M----14.47%1.65B----19.45%1.45B
-Amortization of intangible assets ----7.29%109.1M----13.09%101.69M-----88.22%89.92M-----2.97%763.49M----8.21%786.83M
Financial expense ----16.40%511.07M----42.27%439.06M-----4.56%308.62M----40.63%323.37M----50.04%229.95M
Special items -----56.23%64.09M------146.42M------------------------
Operating profit before the change of operating capital -----1.50%7.24B----14.31%7.35B----6.79%6.43B-----10.23%6.02B----17.93%6.71B
Change of operating capital
Inventory (increase) decrease ----134.60%135.32M-----580.47%-391.1M----74.05%-57.48M----50.73%-221.45M-----339.93%-449.44M
Accounts receivable (increase)decrease -----36.03%-639.41M----70.90%-470.06M-----975.26%-1.62B-----176.52%-150.22M----145.00%196.31M
Accounts payable increase (decrease) -----37.28%696.68M----29.49%1.11B----19.61%857.86M----217.31%717.19M-----81.97%226.02M
prepayments (increase)decrease ----7.52%-480.79M-----226.96%-519.9M----293.39%409.49M-----4.09%-211.74M----56.41%-203.41M
Special items for working capital changes -----290.73%-142.32M----12.64%74.62M-----48.06%66.25M----343.93%127.55M-----849.67%-52.29M
Cash  from business operations -----4.82%6.81B----17.47%7.16B-----3.05%6.09B-----2.21%6.28B----8.32%6.43B
Other taxs ----16.31%-746.57M-----22.76%-892.09M----24.24%-726.72M----12.97%-959.18M-----31.43%-1.1B
Special items of business 15.25%3.08B-----32.36%2.67B----69.08%3.95B----50.14%2.34B-----55.65%1.56B----
Net cash from operations 15.25%3.08B-3.18%6.07B-32.36%2.67B16.75%6.27B69.08%3.95B0.77%5.37B50.14%2.34B0.01%5.33B-55.65%1.56B4.52%5.32B
Cash flow from investment activities
Interest received - investment -----4.28%192.81M----24.30%201.44M-----16.47%162.06M-----21.25%194M----68.89%246.36M
Dividend received - investment --751.5M-44.83%492.91M-----77.76%893.45M----46,383.92%4.02B----122.33%8.64M-----68.02%3.89M
Loan receivable (increase) decrease ------------318.80%70.43M----39.71%-32.19M----13.97%-53.39M-----1,873.17%-62.06M
Decrease in deposits (increase) -38.37%-3.8B107.86%300.52M-5.42%-2.74B-62.20%-3.82B-510.08%-2.6B-6.87%-2.36B--634.89M-162.80%-2.2B-----1,623.13%-838.99M
Sale of fixed assets ----262.09%100.99M-----78.90%27.89M----30.69%132.2M----60.31%101.15M----267.66%63.09M
Purchase of fixed assets 45.95%-407.5M14.12%-1.07B-20.25%-753.91M27.47%-1.24B-7.06%-626.97M-20.35%-1.71B---585.61M1.74%-1.42B----6.48%-1.45B
Purchase of intangible assets -----34.28%-406.78M-----98.10%-302.94M----57.99%-152.92M-----27.95%-363.99M-----123.93%-284.48M
Sale of subsidiaries --1.41B383.11%413.81M-------146.17M--------------------18.88%170M
Acquisition of subsidiaries -------1.16B--458K-----------798.75M---757.16M---------137.00%-391.67M
Recovery of cash from investments ----0.53%512.22M----1.16%509.52M----65.28%503.67M-----5.53%304.74M-----15.84%322.58M
Cash on investment -338.86%-1.69B47.99%-130.39M88.60%-384.45M90.59%-250.71M-116.05%-3.37B70.73%-2.66B---1.56B-890.78%-9.1B-----292.36%-918.71M
Other items in the investment business 980.62%1.69B-5.58%-8.74M-131.32%-191.99M-102.14%-8.28M134.29%612.94M-91.77%386.51M-16.54%-1.79B785.50%4.69B30.61%-1.53B44.56%-684.88M
Net cash from investment operations 49.91%-2.04B81.40%-756.98M31.97%-4.07B-61.80%-4.07B-47.68%-5.99B67.93%-2.52B-164.48%-4.06B-105.15%-7.85B30.61%-1.53B-520.73%-3.82B
Net cash before financing 173.92%1.04B141.93%5.31B31.22%-1.4B-23.01%2.19B-18.62%-2.04B213.10%2.85B-7,932.88%-1.72B-267.98%-2.52B-98.31%21.96M-66.50%1.5B
Cash flow from financing activities
New borrowing -38.57%6.71B25.03%12.19B41.55%10.93B593.65%9.75B1,310.46%7.72B-8.57%1.41B--547.29M-81.68%1.54B----2,006.73%8.39B
Refund 7.91%-9.4B-46.25%-10.28B-55.11%-10.2B-174.02%-7.03B-716.55%-6.58B-45.80%-2.57B---805.6M44.93%-1.76B-----3,306.59%-3.2B
Interest paid - financing -----41.62%-480.83M-----89.02%-339.52M----16.57%-179.62M----36.60%-215.31M-----121.58%-339.6M
Dividends paid - financing -62.85%-889.22M-29.99%-3.85B-494.20%-546.05M-119.42%-2.97B70.83%-91.9M50.22%-1.35B---315.04M-34.33%-2.71B-----15.33%-2.02B
Issuance expenses and redemption of securities expenses 90.73%-361.55M-58.22%-4.02B-65.88%-3.9B-327.88%-2.54B---2.35B-203.81%-593.56M-----509.59%-195.37M----94.70%-32.05M
Other items of the financing business 48.00%-164.97M-376.78%-63.52M-101.50%-317.28M-83.63%22.95M16.39%-157.46M-97.51%140.16M-103.69%-188.34M19,766.73%5.63B513.25%5.11B2.82%28.34M
Net cash from financing operations -1.42%-4.1B-105.53%-6.55B-176.76%-4.04B1.21%-3.19B-91.75%-1.46B-244.42%-3.23B-114.90%-761.69M-20.27%2.23B513.25%5.11B228.61%2.8B
Effect of rate -69.04%26.27M91.29%90.52M358.23%84.83M107.28%47.32M71.12%-32.85M-332.03%-649.71M-17.28%-113.77M194.59%280.02M-394.28%-97M-60.80%95.05M
Net Cash 43.77%-3.06B-25.02%-1.24B-55.54%-5.45B-164.59%-992.05M-41.06%-3.5B-30.63%-374.95M-148.36%-2.48B-106.67%-287.03M8,370.28%5.13B86.96%4.3B
Begining period cash -13.28%7.51B-9.84%8.65B-9.84%8.65B-9.64%9.6B-9.64%9.6B-0.07%10.62B-0.07%10.62B70.51%10.63B70.51%10.63B68.88%6.24B
Cash at the end 35.69%4.47B-13.28%7.51B-45.69%3.29B-9.84%8.65B-24.45%6.07B-9.64%9.6B-48.76%8.03B-0.07%10.62B147.55%15.67B70.51%10.63B
Cash balance analysis
Cash and bank balance -----------------24.46%4.21B-----38.23%5.58B----111.68%9.03B----
Cash and cash equivalent balance -----------------24.46%4.21B-----38.23%5.58B----111.68%9.03B----
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data